ArticleAnnals of surgical oncology2026
Enhanced Recovery After Liver Surgery: Does Compliance Impact Survival?
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEnhanced recovery programs (ERPs) improve short-term outcomes after liver surgery (LS), but their impact on survival remains uncertain. This study evaluated the association between ERP compliance and survival in a large multicenter cohort.
methodsThis prospective European multicenter cohort included adults undergoing elective LS between 2016 and 2024 in 10 centers implementing Enhanced Recovery After Surgery (ERAS)-consistent ERPs. Compliance was defined as the proportion of 21 fulfilled items with high compliance (≥70%). A 1:1 propensity score-matching was performed to balance baseline characteristics. The primary outcome was 12 month overall survival (OS). Secondary outcomes included predictors of 12 month and long-term OS and cancer-specific subgroup analyses. Cox regression models, Kaplan-Meier analyses, and sensitivity analyses including center effects were used.
resultsAmong 1860 patients, 453 (24.4%) achieved high ERP compliance. After matching, 437 well-balanced pairs (n = 874) were analyzed. The 12-month OS did not differ significantly between the high- and low-compliance groups before (95% vs. 92%; p = 0.081) or after (96% vs. 92%; p = 0.11) matching. In the matched cohort, high ERP compliance was not independently associated with 12 month mortality (adjusted hazard ratio, 0.68; 95% confidence interval, 0.36-1.30; p = 0.20). Long-term mortality was independently associated with metastatic disease, operative duration longer than180 min, and intraoperative hypotension. In subgroup analyses after matching, improved survival with high compliance was observed only for patients with colorectal liver metastases (p = 0.029).
conclusionHigh ERP compliance reduces perioperative morbidity but is not independently associated with 12 month or long-term survival after LS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.